Publications
Book Chapters
Chella N., Shastri N.R. (2017) Lipid Carriers: Role and Applications in Nano Drug Delivery. In: Jana S., Jana S. (eds) Particulate Technology for Delivery of Therapeutics. Springer, Singapore. https://doi.org/10.1007/978-981-10-3647-7_8
Chella Naveen, Nalini R. Shastri, Polysaccharide nanomicelles as drug carriers, Editor(s): Sabyasachi Maiti, Sougata Jana, Polysaccharide Carriers for Drug Delivery, Woodhead Publishing,2019,Pages 339-363,ISBN 9780081025536,https://doi.org/10.1016/B978-0-08-102553-6.00012-X.
Saka R., Chella N. (2020) Nanocarriers as Tools for Delivery of Nature Derived Compounds and Extracts with Therapeutic Activity. In: Saneja A., Panda A., Lichtfouse E. (eds) Sustainable Agriculture Reviews 44. Sustainable Agriculture Reviews, vol 44. Springer, Cham. https://doi.org/10.1007/978-3-030-41842-7_3
Jain H., Chella N. (2020) Solubility Enhancement Techniques for Natural Product Delivery. In: Saneja A., Panda A., Lichtfouse E. (eds) Sustainable Agriculture Reviews 43. Sustainable Agriculture Reviews, vol 43. Springer, Cham. https://doi.org/10.1007/978-3-030-41838-0_2
Vemula, S.K.,Amruta Prabhakar Padakanti, Naveen Chella, Sagar Narala, Preethi Lakkala, Nagarjuna Narala & Siva Ram Munnangi (2024). API and Polymer Selection: Formulation and Process Variables. In: Repka, M.A., Langley, N. (eds) 3D Printing . AAPS Advances in the Pharmaceutical Sciences Series, vol 44. Springer, Cham. https://doi.org/10.1007/978-3-031-46015-9_6.
Chenkual, L., Lalchandani, D.S., Padakanti, A.P., Chella, N., Porwal, P.K. (2023). Synthesis and Self-Assembly of Block Copolymers. In: Mishra, N., Pandey, V. (eds) Block Co-polymeric Nanocarriers: Design, Concept, and Therapeutic Applications. Springer, Singapore. https://doi.org/10.1007/978-981-99-6917-3_4.
Research Papers
Kolimi PR, Padakanti AP, Kolagani N, Ponneganti S, Gangipangi V, Selvaraju S, et al. Polymeric amorphous dispersion as a carrier to enhance the in vitro dissolution in vivo pharmacokinetics and cytotoxicity of niclosamide. Polym Adv Technol. 2023 Aug 22;
2. Sharma R, Jain H, Pratibha, Godugu C, Chella N. Formulation and optimization of aceclofenac loaded hyaluronic-oleic acid based micellar gel for the management of osteoarthritis. J Drug Deliv Sci Technol. 2023;84.
3. Pal LB, Bule P, Khan W, Chella N. An Overview of the Development and Preclinical Evaluation of Antibody–Drug Conjugates for Non-Oncological Applications. Pharmaceutics. 2023 Jun 24;15(7):1807.
4. Syamprasad NP, Madje N, Bachannagari J, Jannu AK, Jain S, Tene K, et al. Niclosamide nanocrystal for enhanced in-vivo efficacy against gastrointestinal stromal tumor via regulating EGFR/STAT-3/DR-4 axis. J Drug Deliv Sci Technol. 2023;81.
5. Nayakula M, Jeengar MK, Naidu VGM, Chella N. Enhanced Pharmacokinetics and Anti-inflammatory Activity of Curcumin Using Dry Emulsion as Drug Delivery Vehicle. Eur J Drug Metab Pharmacokinet. 2023;48(2):189–99.
6. Padakanti AP, Pawar SD, Kumar P, Chella N. Development and validation of HPLC method for simultaneous estimation of erlotinib and niclosamide from liposomes optimized by screening design. J Liposome Res. 2023;
7. Ghosh A, Ghosh B, Parihar N, Ilaweibaphyrnai M, Panda SR, Alexander A, et al. Nutraceutical prospects of Houttuynia cordata against the infectious viruses. Food Biosci. 2022;50.
8. Ganthala PD, Alavala S, Chella N, Andugulapati SB, Bathini NB, Sistla R. Co-encapsulated nanoparticles of Erlotinib and Quercetin for targeting lung cancer through nuclear EGFR and PI3K/AKT inhibition. Colloids Surf B Biointerfaces [Internet]. 2022 Mar;211:112305. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0927776521007517
9. Jannu AK, Puppala ER, Gawali B, Syamprasad NP, Alexander A, Marepally S, et al. Lithocholic acid-tryptophan conjugate (UniPR126) based mixed micelle as a nano carrier for specific delivery of niclosamide to prostate cancer via EphA2 receptor. Int J Pharm. 2021;605.
10. Saka R, Chella N, Khan W. Development of Imatinib Mesylate-Loaded Liposomes for Nose to Brain Delivery: In Vitro and In Vivo Evaluation. AAPS PharmSciTech. 2021;22(5).
11. Rampaka R, Ommi K, Chella N. Role of solid lipid nanoparticles as drug delivery vehicles on the pharmacokinetic variability of Erlotinib HCl. J Drug Deliv Sci Technol. 2021 Dec;66:102886. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1773224721005669
12. Jain H, Chella N. Methods to improve the solubility of therapeutical natural products: a review. Environ Chem Lett. 2021;19(1):111–21.
13. Saka R, Chella N. Nanotechnology for delivery of natural therapeutic substances: a review. Environ Chem Lett. 2021;19(2):1097–106.
14. Saka R, Jain H, Kommineni N, Chella N, Khan W. Enhanced penetration and improved therapeutic efficacy of bexarotene via topical liposomal gel in imiquimod induced psoriatic plaque model in BALB/c mice. J Drug Deliv Sci Technol. 2020;58.
15. Kommineni N, Pandi P, Chella N, Domb AJ, Khan W. Antibody drug conjugates: Development, characterization, and regulatory considerations. Polym Adv Technol. 2020;31(6):1177–93.
16. Lodagekar A, Chavan RB, Mannava MKC, Yadav B, Chella N, Nangia AK, et al. Co amorphous valsartan nifedipine system: Preparation, characterization, in vitro and in vivo evaluation. European Journal of Pharmaceutical Sciences. 2019;139.
17. Lodagekar A, Borkar RM, Thatikonda S, Chavan RB, Naidu VGM, Shastri NR, et al. Formulation and evaluation of cyclodextrin complexes for improved anticancer activity of repurposed drug: Niclosamide. Carbohydr Polym [Internet]. 2019 May;212:252–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0144861719301833
18. Lodagekar A, Chavan RB, Chella N, Shastri NR. Role of Valsartan as an Antiplasticizer in Development of Therapeutically Viable Drug-Drug Coamorphous System. Cryst Growth Des. 2018;18(4):1944–50.
19. Daravath B, Naveen C, Vemula SK, Tadikonda RR. Solubility and dissolution enhancement of flurbiprofen by solid dispersion using hydrophilic carriers. Brazilian Journal of Pharmaceutical Sciences. 2018 May 7;53(4).
20. Nooli M, Chella N, Kulhari H, Shastri NR, Sistla R. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation. Drug Dev Ind Pharm. 2017;43(4):611–7.
21. Johnsirani P, Ch. V, Lingesh A, Naidu VGM, Ch. N, Satheeshkumar N. Isolation, characterization using LC-ESI-QTOF, NMR and in vitro cytotoxicity assay of niclosamide forced degradation products. J Pharm Biomed Anal. 2017;136.
22. Jeengar MK, Rompicharla SVK, Shrivastava S, Chella N, Shastri NR, Naidu VGM, et al. Emu oil based nano-emulgel for topical delivery of curcumin. Int J Pharm. 2016;506(1–2):222–36.
23. Chella N, Daravath B, Kumar D, Tadikonda RR. Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan. Eur J Drug Metab Pharmacokinet. 2016;41(5):517–26.
24. Bari A, Chella N, Sanka K, Shastri NR, Diwan PV. Improved anti-diabetic activity of glibenclamide using oral self nano emulsifying powder. J Microencapsul. 2015;32(1):54–60.
25. Narayana L, Chella N, Kumar D, Shastri NR. Design of a novel type IV lipid-based delivery system for improved delivery of drugs with low partition coefficient. J Liposome Res. 2015;25(4):325–33.
26. Chella N, Tadikonda R. Melt dispersion granules: Formulation and evaluation to improve oral delivery of poorly soluble drugs-a case study with valsartan. Drug Dev Ind Pharm. 2015;41(6):888–97.
27. Chella N, Narra N, Rama Rao T. Preparation and Characterization of Liquisolid Compacts for Improved Dissolution of Telmisartan. J Drug Deliv. 2014 Oct 12;2014:1–10.
28. VGM Naidu WKCNYVG. Nano Boom: Opportunities in India. Nano Digest. 2013;4(7):28–31.
29. Chella N, Shastri N, Tadikonda RR. Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan. Acta Pharm Sin B. 2012;2(5):502–8.
30. Naveen Chella KKYRV. Preparation and evaluation of ethyl cellulose microspheres containing diclofenac sodium by novel w/o/o emulsion method. Journal of Pharmaceutical Sciences and Research. 2010;2(12):884–8.